Cell Phone-Enabled Diagnostics Market Sees Lucrative Prospects in Developing Nations

Published Date : Dec 30, 2015

Developing countries worldwide are looking to build advanced healthcare systems that will be easily accessible across urban and rural population. Rapid proliferation of smartphones around the world, has provided the healthcare industry with a viable option of making quality healthcare services accessible to a large pool of patients who until now have remained deprived of the same. The advent of cellphone-enabled diagnostics will help the healthcare industry achieve their goal of boosting sales across the emerging nations. 

The most prominent companies and foundations operating in the healthcare industry have been proactively involved in the development of the technology to link IVD products to cellphones, with an aim to provide prompt results, and in some special cases even remote consultation. Market analysts are encouraging the use of cellphone-enabled diagnostic applications since these technologies provide facilities that are the utmost need of an expanding healthcare system across the world. 

A majority of the diagnostic products introduced in the market are cell phone enabled. For instance a few of the smartphone applications launched recently are intended to help diabetes patients monitor their health. These apps having features enabling glucose management, have been successful to capture laud from the healthcare industry as well as the patient population. Other cell-phone enabled diagnostics available in the market help send images of patients suffering from immunoassays or other infectious diseases for consultations. Some of the recent examples of such apps include Accu-Chek® Glucose Buddy by Roche available as iPhone app, and Smart e-SMBG by Arkray, which is an android app. Other apps are already under development, which will help people suffering from sexually transmittable diseases or other infectious diseases. The recently conducted market research reports suggest that these innovations are arriving just in time for an in-vitro diagnostics industry that is looking forward to boost its operations across the emerging nations. 

With an increasing number of smartphone users around the world, the demand for advanced applications providing better access to healthcare facilities will significantly increase. The cell phone technology therefore, is expected to bridge the gap created by inadequate healthcare infrastructure particularly in developing nations. Likewise, the cellphone-enabled diagnostics is likely to make quality healthcare services available even to the people living in the rural areas with mobile connectivity.